Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:51:53 EDT Sun 28 Apr 2024
Enter Symbol
or Name
USA
CA



Q:AXIM - AXIM BIOTECHNOLOGIES INC - https://aximbiotech.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AXIM - Qnot subscribed0.0137+0.0014511.8126.51210.0133  0.01485  0.01240.0399  0.00915:11:46Mar 2715 min RT 2¢

Recent Trades - Last 10 of 21
Time ETExPriceChangeVolume
15:11:46Q0.01370.001453,000
15:09:24Q0.01380.001558,700
15:09:14Q0.01240.00015100
14:59:31Q0.01380.0015517,400
14:59:24Q0.013250.001100
14:40:40Q0.01380.001552,000
14:36:16Q0.013250.00150
11:55:22Q0.01480.002552,420
10:06:56Q0.01470.002451
09:58:10Q0.013750.001599

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-27 09:00U:AXIMNews ReleaseVIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
2024-02-20 09:00U:AXIMNews ReleaseAXIM ‚ ® Biotechnologies ¢ € ™ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation
2023-12-20 09:00U:AXIMNews ReleaseAXIM ‚ ® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production
2023-09-12 09:00U:AXIMNews ReleaseAXIM ‚ ® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson ¢ € ™s Disease
2023-08-01 09:00U:AXIMNews ReleaseAXIM ‚ ® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test
2023-07-12 13:37U:AXIMNews ReleaseUpdate: AXIM ‚ ® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
2023-07-12 09:00U:AXIMNews ReleaseAXIM ‚ ® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
2023-05-24 09:53U:AXIMNews ReleaseAXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch
2023-05-23 09:00U:AXIMNews ReleaseAXIM ‚ ® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit